Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus-Reference-Cited by-同舟云学术

Safety of infliximab therapy in rheumatoid arthritis patients with previous exposure to hepatitis B virus

Published:2013-07-02 Issue:4 Volume:16 Page:408-412
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Zhang Xuewu¹,Zhang Fengchun²,Wu Donghai³,Bao Chunde⁴,Zhu Ping⁵,Zhang Xiao⁶,Huang Cibo⁷,He DongYi⁸,Tao Yi⁹,Fang Yongfei¹⁰,Gu Jieruo¹¹,Wu Huaxiang¹²,Sun Lingyun¹³,Yang Xiuyan¹⁴,Huang Feng¹⁵,Xu Huji¹⁶,Zhao Dongbao¹⁷,Zhang Miaojia¹⁸,Zheng Yi¹⁹,Li Zhanguo¹

Affiliation:

1. Department of Rheumatology and Immunology; Peking University People's Hospital; Beijing China

2. Department of Rheumatology and Immunology; Peking Union Medical College Hospital; Beijing China

3. Department of Rheumatology and Immunology; China-Japan Friendship Hospital; Beijing China

4. Department of Rheumatology and Immunology; Shanghai Jiaotong University Renji Hospital; Shanghai China

5. Department of Rheumatology and Immunology; Xijing Hospital; the Fourth Military Medical University; Xian China

6. Department of Rheumatology and Immunology; Guangdong Provincial People's Hospital; Guangzhou China

7. Department of Rheumatology and Immunology; Beijing Hospital; Beijing China

8. Department of Rheumatology and Immunology; Shanghai Guanghua Hospital; Shanghai China

9. Department of Rheumatology and Immunology; Second Affiliated Hospital of Guangzhou Medical College; Guangzhou China

10. Department of Rheumatology and Immunology; Xinan Affiliated Hospital of the Third Military Medical University; Chongqing China

11. Department of Rheumatology and Immunology, the; Third Affiliated Hospital of Sun Yat-sen University; Guangzhou China

12. Department of Rheumatology and Immunology; Second Affiliated Hospital of Zhejiang University; Hangzhou China

13. Department of Rheumatology and Immunology; Nanjing Drum Tower Hospital; the Affiliated Hospital of Nanjing University Medical School; Nanjing China

14. Department of Rheumatology and Immunology, the ; First Affiliated Hospital of Sun Yat-sen University; Guangzhou China

15. Department of Rheumatology and Immunology; Chinese PLA General Hospital; Beijing China

16. Department of Rheumatology and Immunology; Second Military Medical University; Shanghai China

17. Department of Rheumatology and Immunology; Changhai Hospital; the Second Military Medical University; Shanghai China

18. Department of Rheumatology and Immunology; Jiangsu Provincial People Hospital; Nanjing China

19. Department of Rheumatology and Immunology; Beijing Chaoyang Affiliated Hospital to Capital University of Medical Science; Beijing China

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1756-185X.12125/fullpdf

Reference20 articles.

1. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future;Schett;Arthritis Res Ther,2011

2. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly;Galloway;Rheumatology (Oxford),2011

3. Guidelines for screening, prophylaxis and critical information prior to initiating anti-TNF-alpha treatment;Nordgaard-Lassen;Dan Med J,2012

4. Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs;Mori;Mod Rheumatol,2011

5. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis;Arnett;Arthritis Rheum,1988

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases;RMD Open;2022-11

2. Autoimmune diseases in China;Advances in Immunology;2019

3. Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice;Biologics: Targets and Therapy;2018-01

4. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections;International Journal of Rheumatic Diseases;2014-09-08

5. Safety of Anti-Tumor Necrosis Factor Therapies in Arthritis Patients;Journal of Pharmacy & Pharmaceutical Sciences;2014-07-30